ZeCardio Therapeutics (private company)

ZeCardio Therapeutics is a spinoff of  ZeClinics based on a technology for a disruptive cardiovascular analysis platform for zebrafish larvae

Companies with similar profile to ZeCardio Therapeutics:

Company	Criteria
Aquilón CyL 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
FinnAdvance 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
Sooma Medical 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
Oncoheroes Biosciences 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
Polimerbio 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
InnoUp Farma 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
Fesia Technology 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
MoWoot 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
eKuore 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
RheoDx 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
Derma Innovate 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Capital Cell Total raised in a similar range: < 1M USD Minim one investor from outside Scandinavia: Yes
NMD Pharma 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Vytrus Biotech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
VOC Diagnostics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
AFYX Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Biograil 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
EnginZyme 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
In Singulo Solutions AB 44%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: < 1M USD
Sanifit Therapeutics 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes
Alvotech 44%	Similar verticals: Biotech, Health services Similar business models: B2B Minim one investor from outside Scandinavia: Yes